JP2005530842A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005530842A5 JP2005530842A5 JP2004515837A JP2004515837A JP2005530842A5 JP 2005530842 A5 JP2005530842 A5 JP 2005530842A5 JP 2004515837 A JP2004515837 A JP 2004515837A JP 2004515837 A JP2004515837 A JP 2004515837A JP 2005530842 A5 JP2005530842 A5 JP 2005530842A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- methacrylate
- group
- pharmaceutically active
- delivery system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/175,716 US20040043067A1 (en) | 2002-06-19 | 2002-06-19 | Fluorosiloxane matrix controlled diffusion drug delivery systems |
| PCT/US2003/019026 WO2004000288A1 (en) | 2002-06-19 | 2003-06-16 | Fluorosiloxane matrix controlled diffusion drug delivery system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005530842A JP2005530842A (ja) | 2005-10-13 |
| JP2005530842A5 true JP2005530842A5 (https=) | 2006-07-27 |
Family
ID=29999052
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004515837A Pending JP2005530842A (ja) | 2002-06-19 | 2003-06-16 | フルオロシロキサンマトリックス制御拡散薬物送達システム |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20040043067A1 (https=) |
| EP (1) | EP1515705B1 (https=) |
| JP (1) | JP2005530842A (https=) |
| CN (1) | CN1662227A (https=) |
| AU (1) | AU2003238247A1 (https=) |
| BR (1) | BR0311963A (https=) |
| CA (1) | CA2489987A1 (https=) |
| CZ (1) | CZ200537A3 (https=) |
| DE (1) | DE60306379T2 (https=) |
| ES (1) | ES2261947T3 (https=) |
| MX (1) | MXPA04012897A (https=) |
| PL (1) | PL375000A1 (https=) |
| RU (1) | RU2307667C2 (https=) |
| TW (1) | TW200404569A (https=) |
| UA (1) | UA80433C2 (https=) |
| WO (1) | WO2004000288A1 (https=) |
| ZA (1) | ZA200409979B (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1765454T3 (en) | 2004-07-02 | 2016-05-02 | Mati Therapeutics Inc | Device for submission of treatment medium to eye |
| US7544371B2 (en) * | 2005-12-20 | 2009-06-09 | Bausch + Lomb Incorporated | Drug delivery systems |
| US20070148244A1 (en) * | 2005-12-22 | 2007-06-28 | Kunzler Jay F | Drug delivery systems |
| US20070218104A1 (en) * | 2006-03-15 | 2007-09-20 | Bausch & Lomb Incorporation | Rate controlled release of a pharmaceutical agent in a biodegradable device |
| US20070218103A1 (en) * | 2006-03-15 | 2007-09-20 | Bausch & Lomb Incorporated | Rate controlled release of a pharmaceutical agent in a biodegradable device |
| EP2004172B1 (en) | 2006-03-31 | 2019-03-13 | Mati Therapeutics Inc. | Drug delivery structures and compositions for nasolacrimal system |
| US7579021B2 (en) * | 2006-09-27 | 2009-08-25 | Bausch & Lomb Incorporated | Drug delivery systems based on degradable cationic siloxanyl macromonomers |
| UY30883A1 (es) * | 2007-01-31 | 2008-05-31 | Alcon Res | Tapones punctales y metodos de liberacion de agentes terapeuticos |
| NZ583858A (en) | 2007-09-07 | 2012-08-31 | Quadra Logic Tech Inc | Lacrimal implant detection with detection device |
| CA2701186C (en) * | 2007-10-05 | 2017-09-19 | Evonik Canada Inc. | Oligofluorinated cross-linked polymers and uses thereof |
| AU2010206610A1 (en) * | 2009-01-23 | 2011-08-11 | Qlt Inc. | Sustained released delivery of one or more agents |
| US9974685B2 (en) | 2011-08-29 | 2018-05-22 | Mati Therapeutics | Drug delivery system and methods of treating open angle glaucoma and ocular hypertension |
| ES2727203T3 (es) | 2011-08-29 | 2019-10-14 | Mati Therapeutics Inc | Administración por liberación sostenida de agentes activos para tratar glaucoma e hipertensión ocular |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
| CA1295941C (en) * | 1985-08-16 | 1992-02-18 | Rajan Bawa | Sustained-release formulation comprising a hydrophobic polymer system |
| IL91398A (en) * | 1988-08-30 | 1994-05-30 | Pfizer | Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane |
| US4882377A (en) * | 1988-09-21 | 1989-11-21 | Dow Corning Corporation | Low-viscosity pressure-adherent silicone elastomer compositions |
| US5321108A (en) * | 1993-02-12 | 1994-06-14 | Bausch & Lomb Incorporated | Fluorosilicone hydrogels |
| US5463010A (en) * | 1993-11-12 | 1995-10-31 | Surface Engineering Technologies, Division Of Innerdyne, Inc. | Hydrocyclosiloxane membrane prepared by plasma polymerization process |
| US6322815B1 (en) * | 1994-07-22 | 2001-11-27 | W. Mark Saltzman | Multipart drug delivery system |
| DE69615393T2 (de) * | 1995-12-07 | 2002-07-04 | Bausch & Lomb Inc., Rochester | Monomere zur reduzierung des modulus von siloxynhydrogele |
| BR9611859A (pt) * | 1995-12-07 | 1999-05-04 | Bausch & Lomb | Composição de silicone polimérico com baixo teor de água lente de contato e método para produzir uma composição de silicone polimérico com baixo teor de água |
| US6296873B1 (en) * | 1997-01-23 | 2001-10-02 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Zero-order sustained release delivery system for carbamazephine derivatives |
| ATE279461T1 (de) * | 1997-04-03 | 2004-10-15 | Guilford Pharm Inc | Bioabbaubare terephthalat polyester-polyphosphat polymere, zusammensetzungen, gegenstände und verfahren für ihre herstellung und verwendung |
| US5908996A (en) * | 1997-10-24 | 1999-06-01 | Timewarp Technologies Ltd | Device for controlling a musical performance |
| US6312728B1 (en) * | 1998-07-07 | 2001-11-06 | Cascade Development, Inc. | Sustained release pharmaceutical preparation |
| TWI284048B (en) * | 2000-01-27 | 2007-07-21 | Zentaris Ag | Compressed microparticles for dry injection |
-
2002
- 2002-06-19 US US10/175,716 patent/US20040043067A1/en not_active Abandoned
-
2003
- 2003-06-16 MX MXPA04012897A patent/MXPA04012897A/es active IP Right Grant
- 2003-06-16 RU RU2005100840/04A patent/RU2307667C2/ru not_active IP Right Cessation
- 2003-06-16 UA UAA200500490A patent/UA80433C2/uk unknown
- 2003-06-16 CN CN038144662A patent/CN1662227A/zh active Pending
- 2003-06-16 CZ CZ20050037A patent/CZ200537A3/cs unknown
- 2003-06-16 DE DE60306379T patent/DE60306379T2/de not_active Expired - Fee Related
- 2003-06-16 AU AU2003238247A patent/AU2003238247A1/en not_active Abandoned
- 2003-06-16 JP JP2004515837A patent/JP2005530842A/ja active Pending
- 2003-06-16 EP EP03737141A patent/EP1515705B1/en not_active Expired - Lifetime
- 2003-06-16 PL PL03375000A patent/PL375000A1/xx not_active Application Discontinuation
- 2003-06-16 WO PCT/US2003/019026 patent/WO2004000288A1/en not_active Ceased
- 2003-06-16 BR BR0311963-7A patent/BR0311963A/pt not_active IP Right Cessation
- 2003-06-16 CA CA002489987A patent/CA2489987A1/en not_active Abandoned
- 2003-06-16 ES ES03737141T patent/ES2261947T3/es not_active Expired - Lifetime
- 2003-06-18 TW TW092116547A patent/TW200404569A/zh unknown
-
2004
- 2004-12-09 ZA ZA200409979A patent/ZA200409979B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005530842A5 (https=) | ||
| JP2002348393A5 (https=) | ||
| US20060018949A1 (en) | Injectable biodegradable drug delivery system | |
| CN100350976C (zh) | 用于眼部药物递送的可逆胶凝系统 | |
| JP7419499B2 (ja) | 湿式充填のソフトヒドロゲル眼用インサート | |
| AU2006210416A1 (en) | Contact drug delivery system | |
| JP2007509902A5 (https=) | ||
| WO2004090613A1 (ja) | 薬物徐放性眼用レンズ及びそれに用いる保存液 | |
| US20220380761A1 (en) | Oral delivery of oligonucleotides | |
| RU2005100840A (ru) | Фторсилоксановые матриксные системы доставки лекарств с регулируемой диффузией | |
| CA2325386A1 (en) | Hydrogel compositions useful for the sustained release of macromolecules and methods of making same | |
| JP2004534739A5 (https=) | ||
| US10940109B2 (en) | Multilayer polymeric matrix based medical devices | |
| CN117545509A (zh) | 寡核苷酸的口服递送 | |
| JPS62103028A (ja) | 疎水性ポリマ−系を含む持効性製剤 | |
| JP2010504318A5 (https=) | ||
| US20060078592A1 (en) | Drug delivery systems | |
| CN1644215A (zh) | 一种眼用嵌段聚合物 | |
| Schacht | Hydrogel drug delivery systems physical and ionogenic drug carriers | |
| US20060198892A1 (en) | Polymeric systems for controlled drug therapy | |
| JP2025136503A (ja) | 眼表面薬物滞留化剤および該剤を含有する点眼剤 | |
| US20240207409A1 (en) | Oral delivery of oligonucleotides | |
| JP2026059162A (ja) | 眼科用医療器具用印刷インク、眼科用医療器具、眼科用医療器具の製造方法及び薬剤含有眼科用医療器具の製造方法 | |
| KR20050021025A (ko) | 플루오로실록산 매트릭스 조절 확산 약물 전달계 | |
| JPWO1999026637A1 (ja) | 眼科用剤及び眼科用組成物 |